IMS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of IMS Health Holdings, Inc. (IMS) Over the Proposed Sale of the Company to Quintiles Transnational Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of IMS Health Holdings, Inc. (“IMS” or the “Company”) (NYSE:IMS) for potential breaches of fiduciary duties in connection with the sale of the Company to Quintiles Transnational Holdings, Inc. for approximately $8.75 billion.